Atlas Private Wealth Management Novavax Inc Transaction History

Atlas Private Wealth Management

  • $227 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$121.0 - $257.67 $10,285 - $21,901
-85 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$78.74 - $139.5 $6,692 - $11,857
85 New
85 $9,000
Q3 2020

Nov 05, 2020
SELL
$79.44 - $178.51 $7,944 - $17,851
-100 Closed
0 $0
Q2 2020

Aug 04, 2020
BUY
$13.86 - $83.61 $1,386 - $8,361
100 New
100 $8,000

Others Institutions Holding NVAX

# of Institutions
291
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $674M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Atlas Private Wealth Management Portfolio

Follow Atlas Private Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Private Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email